Google announces blockchain development

Cara Livernois | | Health Exec | Cybersecurity

Google has now announced it is developing blockchain solutions aimed at ensuring the safety of its cloud systems.

Blockchain, the digital ledger for recording online transactions, ensures data is transferred and stored securely. For Google, the development of blockchain into its cloud-based services would build trust in their ability to protect their user’s information. Specifically, the Alphabet, the parent company of Google, is developing its own blockchain ledger for third parties to utilize in recording and verifying transactions.

Google Is Working on Its Own Blockchain-Related Technology

“Like many new technologies, we have individuals in various teams exploring potential uses of blockchain but it’s way too early for us to speculate about any possible uses or plans,” a Google spokesman told Bloomberg.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

UnitedHealth subsidiary exposes 5.5M patient records to hackers
Kettering Health hit with class-action lawsuit weeks after ransomware attack
Dental marketing firm Gargle likely source of 8M leaked patient records
Fraud prevention expert charged with over 167 suspected incidents of healthcare fraud
GE HealthCare recalls legacy cardiology information systems due to security risk
Interlock claims responsibility for Kettering cyberattack, stolen data listed for sale

Around the web

Cardiovascular Business
AMA agrees to help after initial request for an independent cardiovascular board was denied

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.